NO148291C - Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater

Info

Publication number
NO148291C
NO148291C NO771301A NO771301A NO148291C NO 148291 C NO148291 C NO 148291C NO 771301 A NO771301 A NO 771301A NO 771301 A NO771301 A NO 771301A NO 148291 C NO148291 C NO 148291C
Authority
NO
Norway
Prior art keywords
theophylinine
derivatives
preparation
therapeutic active
active basic
Prior art date
Application number
NO771301A
Other languages
English (en)
Norwegian (no)
Other versions
NO148291B (no
NO771301L (no
Inventor
Heribert Offermanns
Karl Heinz Klingler
Klaus Thiemer
Fritz Stroman
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of NO771301L publication Critical patent/NO771301L/no
Publication of NO148291B publication Critical patent/NO148291B/no
Publication of NO148291C publication Critical patent/NO148291C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO771301A 1976-04-15 1977-04-14 Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater NO148291C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB15547/76A GB1527543A (en) 1976-04-15 1976-04-15 Basically substituted xanthine derivatives

Publications (3)

Publication Number Publication Date
NO771301L NO771301L (no) 1977-10-18
NO148291B NO148291B (no) 1983-06-06
NO148291C true NO148291C (no) 1983-09-14

Family

ID=10061083

Family Applications (1)

Application Number Title Priority Date Filing Date
NO771301A NO148291C (no) 1976-04-15 1977-04-14 Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater

Country Status (28)

Country Link
US (1) US4144340A (sh)
JP (1) JPS52128396A (sh)
AR (1) AR217426A1 (sh)
AT (1) AT350070B (sh)
AU (1) AU511983B2 (sh)
BE (1) BE853571A (sh)
CA (1) CA1078379A (sh)
CH (1) CH631454A5 (sh)
CS (1) CS196357B2 (sh)
DE (1) DE2716210A1 (sh)
DK (1) DK141051B (sh)
ES (2) ES457784A1 (sh)
FI (1) FI61900C (sh)
FR (1) FR2361395A1 (sh)
GB (1) GB1527543A (sh)
GR (1) GR63643B (sh)
IN (1) IN145872B (sh)
IT (1) IT1143568B (sh)
MX (1) MX5064E (sh)
NL (1) NL7704087A (sh)
NO (1) NO148291C (sh)
NZ (1) NZ183859A (sh)
PL (1) PL106083B1 (sh)
PT (1) PT66442B (sh)
RO (1) RO72835A (sh)
SE (1) SE431335B (sh)
SU (1) SU668604A3 (sh)
ZA (1) ZA772294B (sh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935062A1 (de) * 1978-09-06 1980-03-20 Degussa Substituierte aminoalkylguanidine, deren herstellung und arzneimittel
EP0022321A1 (en) * 1979-07-10 1981-01-14 Beecham Group Plc Benzene derivatives, their preparation and use in pharmaceutical compositions
DE2929596A1 (de) * 1979-07-21 1981-02-05 Hoechst Ag Verfahren zur herstellung von oxoalkyl-xanthinen
CH655658B (sh) * 1980-09-18 1986-05-15
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4406903A (en) * 1981-01-21 1983-09-27 John Wyeth And Brother Limited Xanthine derivatives useful as antidepressives
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT308139B (de) * 1970-07-27 1973-06-25 Degussa Verfahren zur Herstellung von neuen basisch substituierten Alkyltheophyllinen, ihren Isomeren und Säureadditionssalzen
AT311995B (de) * 1971-09-06 1973-12-10 Degussa Verfahren zur Herstellung von neuen basisch substituierten Alkyltheophyllinen
AT313916B (de) * 1971-10-28 1974-03-11 Degussa Verfahren zur Herstellung von neuen basisch substituierten Theophyllinen und deren Säureadditionssalzen
DE2308826C3 (de) * 1973-02-22 1980-03-27 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Phenoxyalkancarbonsäureester von Oxyalkyltheophyllinen, Verfahren zu ihrer Herstellung und Arzneimittel

Also Published As

Publication number Publication date
SU668604A3 (ru) 1979-06-15
AU2425677A (en) 1978-10-19
RO72835B (ro) 1983-07-30
AU511983B2 (en) 1980-09-18
ES457784A1 (es) 1978-03-01
SE431335B (sv) 1984-01-30
RO72835A (ro) 1983-08-03
ZA772294B (en) 1978-03-29
PL106083B1 (pl) 1979-11-30
IT1143568B (it) 1986-10-22
CS196357B2 (en) 1980-03-31
SE7704319L (sv) 1977-11-28
BE853571A (nl) 1977-10-14
CA1078379A (en) 1980-05-27
NO148291B (no) 1983-06-06
AR217426A1 (es) 1980-03-31
JPS52128396A (en) 1977-10-27
PT66442A (pt) 1977-05-01
NZ183859A (en) 1979-03-28
AT350070B (de) 1979-05-10
DK141051B (da) 1979-12-31
ES457783A1 (es) 1978-03-01
FI61900B (fi) 1982-06-30
FR2361395B1 (sh) 1981-02-13
FI61900C (fi) 1982-10-11
GB1527543A (en) 1978-10-04
GR63643B (en) 1979-11-28
FR2361395A1 (fr) 1978-03-10
ATA262677A (de) 1978-10-15
NO771301L (no) 1977-10-18
DK166677A (sh) 1977-10-16
NL7704087A (nl) 1977-10-18
DK141051C (sh) 1980-06-16
CH631454A5 (de) 1982-08-13
US4144340A (en) 1979-03-13
FI771187A (sh) 1977-10-16
MX5064E (es) 1983-03-09
IN145872B (sh) 1979-01-06
DE2716210A1 (de) 1977-11-03
PT66442B (pt) 1978-09-22

Similar Documents

Publication Publication Date Title
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO149586C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO148453C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO150044C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazol-derivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO145951C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO794318L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO146600C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater